Drug
Lebrikizumab-lbkz
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Conjunctivitis | 126 | 76.2 | 81.5 | signal |
| 2 | Dermatitis Atopic | 131 | 29.0 | 31.1 | signal |
| 3 | Eczema | 108 | 23.7 | 25.1 | signal |
| 4 | Incorrect Dose Administered By Device | 38 | 16.5 | 16.9 | signal |
| 5 | Eye Pruritus | 43 | 14.4 | 14.7 | signal |
| 6 | Sleep Disorder Due To A General Medical Condition | 19 | 13.0 | 13.1 | signal |
| 7 | Skin Fissures | 21 | 12.3 | 12.4 | signal |
| 8 | Ocular Hyperaemia | 51 | 12.1 | 12.4 | signal |
| 9 | Eye Discharge | 11 | 11.9 | 12.0 | signal |
| 10 | Injection Site Discomfort | 10 | 10.7 | 10.7 | signal |
| 11 | Skin Haemorrhage | 11 | 8.4 | 8.5 | signal |
| 12 | Lacrimation Increased | 22 | 8.1 | 8.2 | signal |
| 13 | Dermatitis | 15 | 8.0 | 8.0 | signal |
| 14 | Eye Infection | 8 | 7.9 | 7.9 | signal |
| 15 | Eye Irritation | 39 | 7.7 | 7.9 | signal |
| 16 | Injection Site Pain | 207 | 7.5 | 8.3 | signal |
| 17 | Eye Inflammation | 6 | 7.0 | 7.0 | signal |
| 18 | Injection Site Urticaria | 15 | 6.8 | 6.9 | signal |
| 19 | Eye Disorder | 20 | 6.7 | 6.8 | signal |
| 20 | Dry Eye | 29 | 6.6 | 6.7 | signal |
| 21 | Eye Swelling | 22 | 6.6 | 6.6 | signal |
| 22 | Pruritus | 216 | 6.3 | 7.0 | signal |
| 23 | Oral Herpes | 11 | 6.2 | 6.3 | signal |
| 24 | Skin Exfoliation | 45 | 6.0 | 6.1 | signal |
| 25 | Dry Skin | 65 | 5.5 | 5.6 | signal |
| 26 | Ocular Discomfort | 5 | 5.1 | 5.1 | signal |
| 27 | Erythema | 91 | 4.9 | 5.1 | signal |
| 28 | Injection Site Reaction | 30 | 4.8 | 4.9 | signal |
| 29 | Injection Site Swelling | 29 | 4.2 | 4.3 | signal |
| 30 | Therapeutic Response Decreased | 23 | 4.2 | 4.2 | signal |
| 31 | Therapeutic Response Shortened | 12 | 4.2 | 4.2 | signal |
| 32 | Drug Effect Less Than Expected | 5 | 3.9 | 3.9 | signal |
| 33 | Underdose | 25 | 3.8 | 3.8 | signal |
| 34 | Injection Site Rash | 10 | 3.6 | 3.7 | signal |
| 35 | Injection Site Irritation | 4 | 3.5 | 3.5 | signal |
| 36 | Injection Site Haemorrhage | 25 | 3.5 | 3.5 | signal |
| 37 | Skin Burning Sensation | 22 | 3.4 | 3.4 | signal |
| 38 | Pain Of Skin | 8 | 3.3 | 3.3 | signal |
| 39 | Injection Site Erythema | 36 | 3.2 | 3.3 | signal |
| 40 | Injection Site Pruritus | 19 | 3.2 | 3.2 | signal |
| 41 | Injection Site Nodule | 3 | 3.0 | 3.0 | no signal |
| 42 | Exposure Via Skin Contact | 6 | 2.9 | 2.9 | signal |
| 43 | Injection Site Warmth | 5 | 2.7 | 2.7 | no signal |
| 44 | Incorrect Dose Administered | 54 | 2.7 | 2.7 | signal |
| 45 | Injection Site Induration | 3 | 2.6 | 2.6 | no signal |
| 46 | Injection Site Mass | 8 | 2.4 | 2.4 | signal |
| 47 | Injection Site Bruising | 15 | 2.1 | 2.1 | signal |
| 48 | Product Administered At Inappropriate Site | 3 | 1.8 | 1.8 | no signal |
| 49 | Drug Dose Omission By Device | 8 | 1.2 | 1.2 | no signal |
| 50 | Accidental Exposure To Product | 9 | 1.0 | 1.0 | no signal |